Thermo Fisher raises 2026 guidance after strong third-quarter results
Thermo Fisher reported third-quarter revenue up 9% and adjusted EPS up 15%, and lifted its full-year 2026 guidance for revenue, EPS and free cash flow.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Thermo Fisher Scientific (TMO) reported third-quarter revenue growth of 9%, organic growth of 6%, and a 15% rise in adjusted earnings per share. The increase was broad-based across the company's key markets.
The company raised its full-year 2026 guidance for revenue, earnings per share and free cash flow. It also noted that tariff refunds provided a one-time benefit to earnings. The information comes from TradingView, which labels its own item as an AI-generated summary that may contain inaccuracies.
why it matters
For markets, the result matters because strength shows up across several lines at once, and the guidance increase covers revenue, profit and cash flow. The one-time tariff refund inflates reported earnings, so the durability of growth will be judged largely on organic figures. Results like these often read across to the wider life sciences tools sector.
market impact
TMO: strong quarter and higher guidance support the Thermo Fisher stock and the life sciences sector
tags
instruments
sources
- TMO: Q3 outperformance lifted FY26 guidance as markets strengthened and AI-led investments advanced — TradingView, 21 October 2026 at 13:31 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗